Pneumonia and COVID-19 in Mexico
Issues and Developments in Medicine and Medical Research Vol. 11,
7 March 2022
,
Page 9-17
https://doi.org/10.9734/bpi/idmmr/v11/2289C
Abstract
In this chapter, we present a review of the SARS-CoV-2 and COVID-19 presence among the Mexican population. We also show the effect of pneumonia in people with COVID-19 whose outcome was fatal so far.
For all age groups, pneumonia is one of the leading causes of death among patients diagnosed with COVID-19. It is more frequent because SARS-CoV-2 uses the ACE receptor to enter epithelial cells primarily in the respiratory tract. All ages, from the Mexican population, had pneumonia as a significant risk factor to die due to COVID-19.
In the Mexican population under 19 years of age, a positive correlation and linear relationship between pneumonia and Case Fatality Ratio r=0.79, CFR(%)=0.02 + 0.29 cases with pneumonia(%), t=0.68, P-value=.0001.
In conclusion, pneumonia is a leading cause of death in patients with COVID-19.
- SARS-CoV-2
- Covid-19
- pneumonia
- mortality